Keywords: teturna, cuts, level, proteinuria, diabetics, swiss, drug

Teturna cuts level of proteinuria in diabetics

Article | 19 November 2007

Swiss drug firm Speedel says that data from a Phase III trial of Tekturna (aliskiren, known as Rasilez in Europe) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in